Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.22, $0.04 better than the analyst estimate of $0.18. Revenue for the quarter came in at $130.16 million versus the consensus estimate of $128 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.